Can a targeted electric pulse treatment spare prostate cancer patients from radical surgery?

This trial tests whether a focal treatment called irreversible electroporation (IRE) can control localized prostate cancer as effectively as radical treatments, but with fewer side effects. IRE uses high-voltage electrical pulses to destroy tumor cells while sparing surrounding healthy tissue. The study includes men with MRI-visible, unifocal prostate cancer who are eligible for radical treatment. The main goals are to compare urinary continence and irritative urinary symptoms between the two approaches, with secondary focus on erectile function.